Biomechanical and Ultrasonic Assessment of the Achilles Tendon in Vivo (MEDUSAA) (MEDUSAA)

September 30, 2015 updated by: University Hospital, Tours

Among Musculoskeletal disorders (MSD) the rupture of the Achilles tendon is the most common. Up today, the mechanical and elastic properties of the Achilles tendon are still unknown, and that both in healthy subjects in pathology. The viscoelastic properties or dynamic mechanical properties are directly related to the tendon of the health status and its elongation capacity.

The laboratory UMR Inserm U930 - CNRS ERL 3106 in Tours has developed a non-invasive ultrasonic device, named Achillus, which, via an ultrasonic probe, allowing to access the viscoelastic properties of the tendon during the contraction of the sural triceps.

This is what we want to do in this first protocol: in vivo observation of the normal values and variations, looking for changes related to hyper solicitation and finally trying to highlight a tendon fragility parameter for patients who have experienced of a Achilles tendon rupture.

Study Overview

Detailed Description

Musculoskeletal disorders (MSD) are among the main causes of pain and disability in adults. Tendon disorders are an important part of MSD. Among them, the rupture of the Achilles tendon is the most common, with a prevalence of about 18 to 100000. The disorder mostly affects men between 30 and 50 years. Up today, the mechanical and elastic properties of the Achilles tendon are still unknown, and that both in healthy subjects in pathology. The viscoelastic properties or dynamic mechanical properties are directly related to the tendon of the health status and its elongation capacity. Additional tests that we have to explore the Achilles tendon are ultrasound and MRI. They bring mainly morphological information but can not demonstrate the mechanical properties of the tendon.

For this purpose, the laboratory UMR Inserm U930 - CNRS ERL 3106 in Tours has developed a non-invasive ultrasonic device, named Achillus, which, via an ultrasonic probe, allowing to access the viscoelastic properties of the tendon during the contraction of the sural triceps. It is therefore important in the exploratory work we propose to have a proven method of calibration of forces applied to the tendon, which is why an ergometer laboratory biomechanics and bioengineering at UT Compiègne is associated with our experiments.

No human study has yet been conducted to evaluate this method in medically relevant situations such as hyper solicitation and incorporated rupture.

This is what we want to do in this first protocol: in vivo observation of the normal values and variations, looking for changes related to hyper solicitation and finally trying to highlight a tendon fragility parameter for patients who have experienced of a Achilles tendon rupture.

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tours, France, 37044
        • Univesity Hospital of Tours

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

Groupe I

  • Male
  • Between 18 and 60 years-old
  • Informed consent form signed
  • Affiliated to medical insurance

Groupe II

  • Male
  • Between 18 and 60 years-old
  • Informed consent form signed
  • Affiliated to medical insurance
  • pathology of lower limb, from surgical treatment, and requiring an immobilization longer than one month and lower than two months, with discharge without support. Inclusion in the study will be done during within 48h from the onset of the immobilization

Groupe III

  • Male
  • Between 18 and 60 years-old
  • Informed consent form signed
  • Affiliated to medical insurance
  • Antecedent of unilateral Achilles tendon breakage during the last 10 years (without breakage during the year previous the inclusion).

Exclusion Criteria:

Groupe I

  • Know pathologies of collagen
  • Antecedent of surgery on studied lower limb, located under the knee
  • Pathology requiring a relief, a sport stoppage prescribed by a physician for a lower limb pathology during the last 12 months
  • Muscular or neurologic pathology with impact on lower limbs
  • Acute pathology able to compromise quality of the research (infectious, organic failure, pain …)
  • Treatments able to affect the results of the research (myorelaxant, molecule changing the muscular tonus, quinolones …)
  • Adult under guardianship
  • Person under an exclusion period of other biomedical research

Groupe II

  • Know pathologies of collagen
  • Antecedent of surgery on studied lower limb, located under the knee
  • Pathology requiring a relief, a sport stoppage prescribed by a physician for a lower limb pathology during the last 12 months
  • Muscular or neurologic pathology with impact on healthy lower limb
  • Acute pathology able to compromise quality of the research (infectious, organic failure, pain …)
  • Treatments able to affect the results of the research (myorelaxant, molecule changing the muscular tonus, quinolones …)
  • Adult under guardianship
  • Person under an exclusion period of other biomedical research

Groupe III

  • Know pathologies of collagen
  • Antecedent of surgery on studied lower limb, located under the knee
  • Pathology requiring a relief, a sport stoppage prescribed by a physician for a lower limb pathology during the last 12 months (including a controlateral Achilles tendon breakage)
  • Muscular or neurologic pathology with impact on lower limbs
  • Acute pathology able to compromise quality of the research (infectious, organic failure, pain …)
  • Treatments able to affect the results of the research (myorelaxant, molecule changing the muscular tonus, quinolones …)
  • Adult under guardianship
  • Person under an exclusion period of other biomedical research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 3 groups of subjects

3 groups:

  • group I : healthy volunters
  • group II : patient with an immobilisation (between 1 and 2 months)
  • group III : patient with an antecedent of Achilles tendon breakage during the 10 past years

Each group have the same interventions : ultrasound exam, IPAQ questionnaire

Ultrasound exam with :

  • 2 successions of 3 measures repeated for 2 visits (day 0 and day 21) for group I
  • 1 succession of 3 measures repeated for 4 visits (day 0, day 14, day 45, day 90)for group II
  • 1 succession of 3 measures for group III
Other Names:
  • Ergometer
  • Achillus
IPAQ questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measures of received signals of the ultrasound sensors and measures of applied strength on the pedal during
Time Frame: up to 3 months

This is the measure of received signals of the ultrasound sensors and measures of applied strength on the pedal during plantar flexion efforts.

Untreated data will be treated to extract this following parameters :

  • Control of rotational strengths couple applied by the participant
  • Simultaneous speed measure of lateral wave along the Achilles tendon The set oh these data will be got with an initial isometric effort at 20, 50, 80% of the de maximal voluntary muscle contraction previously measured
up to 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
score IPAQ questionnaire
Time Frame: up to 3 months
Clinical parameter :score questionnaire of average physical activity of persons, determined by IPAQ questionnaire
up to 3 months
Examination data
Time Frame: baseline
Examination data : age, size, weight, laterality, smoking history
baseline
time of hyper stress
Time Frame: up to 3 months
time of hyper stress
up to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

July 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

September 30, 2015

First Submitted That Met QC Criteria

September 30, 2015

First Posted (Estimate)

October 2, 2015

Study Record Updates

Last Update Posted (Estimate)

October 2, 2015

Last Update Submitted That Met QC Criteria

September 30, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • AORT 2011-FP / MEDUSAA

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alterations of the Achilles Tendon

Clinical Trials on Ultrasound exam

3
Subscribe